tiprankstipranks
Trending News
More News >
Onconetix Inc (ONCO)
:ONCO

Onconetix (ONCO) Price & Analysis

Compare
191 Followers

ONCO Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

2.94%0.15%0.13%96.78%
0.13% Other Institutional Investors
96.78% Public Companies and Individual Investors

ONCO FAQ

What was Onconetix Inc’s price range in the past 12 months?
Onconetix Inc lowest stock price was $3.82 and its highest was $1191.64 in the past 12 months.
    What is Onconetix Inc’s market cap?
    Onconetix Inc’s market cap is $2.09M.
      When is Onconetix Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Onconetix Inc’s earnings last quarter?
      Currently, no data Available
      Is Onconetix Inc overvalued?
      According to Wall Street analysts Onconetix Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Onconetix Inc pay dividends?
        Onconetix Inc does not currently pay dividends.
        What is Onconetix Inc’s EPS estimate?
        Onconetix Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Onconetix Inc have?
        Onconetix Inc has 521,863 shares outstanding.
          What happened to Onconetix Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Onconetix Inc?
          Currently, no hedge funds are holding shares in ONCO

          Onconetix Stock Smart Score

          Company Description

          Onconetix Inc

          Onconetix (ONCO) is a biotechnology company specializing in the development and commercialization of innovative cancer diagnostics and therapeutics. The company operates in the healthcare and life sciences sectors, focusing on leveraging advanced technologies to improve cancer detection, treatment, and patient outcomes. Onconetix's core products include a range of diagnostic assays and personalized treatment solutions designed to target specific cancer biomarkers, thereby enabling more effective and tailored treatment regimens.
          Similar Stocks
          Company
          Price & Change
          Follow
          BioMarin Pharmaceutical
          Exelixis
          Gilead Sciences
          Incyte
          Vertex Pharmaceuticals
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis